Effect of zoledronic acid on tartrate-resistant acid phosphatase isoform 5b (TRAP-5b) and other bone markers in lung cancer patients with bone metastasis
Autor: | Guilherme Rabinowits, C. Li, L. Yam, A. J. Janckila, Damian A. Laber, Goetz H. Kloecker, W. Zhang, F. J. Hendler |
---|---|
Rok vydání: | 2010 |
Předmět: |
Oncology
Gene isoform Cancer Research medicine.medical_specialty business.industry medicine.medical_treatment Bone markers food and beverages Bone metastasis Bisphosphonate medicine.disease Zoledronic acid Internal medicine medicine In patient business Lung cancer medicine.drug Tartrate-resistant acid phosphatase |
Zdroj: | Journal of Clinical Oncology. 28:e18118-e18118 |
ISSN: | 1527-7755 0732-183X |
Popis: | e18118 Background: Between 19 to 44% of patients with lung cancer eventually develop bone metastasis. Zoledronic acid (ZA), a bisphosphonate, can prevent skeletal-related complications in patients ... |
Databáze: | OpenAIRE |
Externí odkaz: |